Literature DB >> 22624711

Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.

Fredrik J Swartling1, Vasil Savov2, Anders I Persson3, Justin Chen3, Christopher S Hackett3, Paul A Northcott4, Matthew R Grimmer3, Jasmine Lau3, Louis Chesler5, Arie Perry3, Joanna J Phillips3, Michael D Taylor4, William A Weiss6.   

Abstract

The proto-oncogene MYCN is mis-expressed in various types of human brain tumors. To clarify how developmental and regional differences influence transformation, we transduced wild-type or mutationally stabilized murine N-myc(T58A) into neural stem cells (NSCs) from perinatal murine cerebellum, brain stem, and forebrain. Transplantation of N-myc(WT) NSCs was insufficient for tumor formation. N-myc(T58A) cerebellar and brain stem NSCs generated medulloblastoma/primitive neuroectodermal tumors, whereas forebrain NSCs developed diffuse glioma. Expression analyses distinguished tumors generated from these different regions, with tumors from embryonic versus postnatal cerebellar NSCs demonstrating Sonic Hedgehog (SHH) dependence and SHH independence, respectively. These differences were regulated in part by the transcription factor SOX9, activated in the SHH subclass of human medulloblastoma. Our results demonstrate context-dependent transformation of NSCs in response to a common oncogenic signal.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22624711      PMCID: PMC3360885          DOI: 10.1016/j.ccr.2012.04.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  58 in total

1.  SOX9 induces and maintains neural stem cells.

Authors:  Charlotte E Scott; Sarah L Wynn; Abdul Sesay; Catarina Cruz; Martin Cheung; Maria-Victoria Gomez Gaviro; Sarah Booth; Bo Gao; Kathryn S E Cheah; Robin Lovell-Badge; James Briscoe
Journal:  Nat Neurosci       Date:  2010-10       Impact factor: 24.884

2.  Pleiotropic role for MYCN in medulloblastoma.

Authors:  Fredrik J Swartling; Matthew R Grimmer; Christopher S Hackett; Paul A Northcott; Qi-Wen Fan; David D Goldenberg; Jasmine Lau; Selma Masic; Kim Nguyen; Slava Yakovenko; Xiao-Ning Zhe; Heather C Flynn Gilmer; Rodney Collins; Mai Nagaoka; Joanna J Phillips; Robert B Jenkins; Tarik Tihan; Scott R Vandenberg; C David James; Kohichi Tanaka; Michael D Taylor; William A Weiss; Louis Chesler
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

3.  Dynamic distribution and stem cell characteristics of Sox1-expressing cells in the cerebellar cortex.

Authors:  Joelle Alcock; Virginie Sottile
Journal:  Cell Res       Date:  2009-10-13       Impact factor: 25.617

4.  Transventricular delivery of Sonic hedgehog is essential to cerebellar ventricular zone development.

Authors:  Xi Huang; Jiang Liu; Tatiana Ketova; Jonathan T Fleming; Vandana K Grover; Michael K Cooper; Ying Litingtung; Chin Chiang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-16       Impact factor: 11.205

5.  Cross-species genomics matches driver mutations and cell compartments to model ependymoma.

Authors:  Robert A Johnson; Karen D Wright; Helen Poppleton; Kumarasamypet M Mohankumar; David Finkelstein; Stanley B Pounds; Vikki Rand; Sarah E S Leary; Elsie White; Christopher Eden; Twala Hogg; Paul Northcott; Stephen Mack; Geoffrey Neale; Yong-Dong Wang; Beth Coyle; Jennifer Atkinson; Mariko DeWire; Tanya A Kranenburg; Yancey Gillespie; Jeffrey C Allen; Thomas Merchant; Fredrick A Boop; Robert A Sanford; Amar Gajjar; David W Ellison; Michael D Taylor; Richard G Grundy; Richard J Gilbertson
Journal:  Nature       Date:  2010-07-18       Impact factor: 49.962

6.  The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.

Authors:  Paul A Northcott; Africa Fernandez-L; John P Hagan; David W Ellison; Wesia Grajkowska; Yancey Gillespie; Richard Grundy; Timothy Van Meter; James T Rutka; Carlo M Croce; Anna Marie Kenney; Michael D Taylor
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

7.  Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.

Authors:  R Sutter; O Shakhova; H Bhagat; H Behesti; C Sutter; S Penkar; A Santuccione; R Bernays; F L Heppner; U Schüller; M Grotzer; H Moch; P Schraml; S Marino
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

8.  Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines.

Authors:  F J Swartling; M Ferletta; M Kastemar; W A Weiss; B Westermark
Journal:  Oncogene       Date:  2009-06-22       Impact factor: 9.867

9.  Subtypes of medulloblastoma have distinct developmental origins.

Authors:  Paul Gibson; Yiai Tong; Giles Robinson; Margaret C Thompson; D Spencer Currle; Christopher Eden; Tanya A Kranenburg; Twala Hogg; Helen Poppleton; Julie Martin; David Finkelstein; Stanley Pounds; Aaron Weiss; Zoltan Patay; Matthew Scoggins; Robert Ogg; Yanxin Pei; Zeng-Jie Yang; Sonja Brun; Youngsoo Lee; Frederique Zindy; Janet C Lindsey; Makoto M Taketo; Frederick A Boop; Robert A Sanford; Amar Gajjar; Steven C Clifford; Martine F Roussel; Peter J McKinnon; David H Gutmann; David W Ellison; Robert Wechsler-Reya; Richard J Gilbertson
Journal:  Nature       Date:  2010-12-08       Impact factor: 49.962

10.  Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.

Authors:  Cameron Brennan; Hiroyuki Momota; Dolores Hambardzumyan; Tatsuya Ozawa; Adesh Tandon; Alicia Pedraza; Eric Holland
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more
  97 in total

1.  Targeting SOX9 for degradation to inhibit chemoresistance, metastatic spread, and recurrence.

Authors:  Aldwin Suryo Rahmanto; Fredrik J Swartling; Olle Sangfelt
Journal:  Mol Cell Oncol       Date:  2016-11-08

Review 2.  Targeted treatment for sonic hedgehog-dependent medulloblastoma.

Authors:  Mark W Kieran
Journal:  Neuro Oncol       Date:  2014-06-20       Impact factor: 12.300

3.  G34, another connection between MYCN and a pediatric tumor.

Authors:  Miller Huang; William A Weiss
Journal:  Cancer Discov       Date:  2013-05       Impact factor: 39.397

4.  Contribution of tumor heterogeneity in a new animal model of CNS tumors.

Authors:  Fuyi Chen; Albert J Becker; Joseph J LoTurco
Journal:  Mol Cancer Res       Date:  2014-02-05       Impact factor: 5.852

Review 5.  Chromatin remodeling defects in pediatric brain tumors.

Authors:  Alexia Klonou; Danai Spiliotakopoulou; Marios S Themistocleous; Christina Piperi; Athanasios G Papavassiliou
Journal:  Ann Transl Med       Date:  2018-06

6.  Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse.

Authors:  Liguo Zhang; Xuelian He; Xuezhao Liu; Feng Zhang; L Frank Huang; Andrew S Potter; Lingli Xu; Wenhao Zhou; Tao Zheng; Zaili Luo; Kalen P Berry; Allison Pribnow; Stephanie M Smith; Christine Fuller; Blaise V Jones; Maryam Fouladi; Rachid Drissi; Zeng-Jie Yang; W Clay Gustafson; Marc Remke; Scott L Pomeroy; Emily J Girard; James M Olson; A Sorana Morrissy; Maria C Vladoiu; Jiao Zhang; Weidong Tian; Mei Xin; Michael D Taylor; S Steven Potter; Martine F Roussel; William A Weiss; Q Richard Lu
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

Review 7.  Medulloblastoma development: tumor biology informs treatment decisions.

Authors:  Vidya Gopalakrishnan; Rong-Hua Tao; Tara Dobson; William Brugmann; Soumen Khatua
Journal:  CNS Oncol       Date:  2015

8.  Mice Expressing Myc in Neural Precursors Develop Choroid Plexus and Ciliary Body Tumors.

Authors:  Morgan L Shannon; Ryann M Fame; Kevin F Chau; Neil Dani; Monica L Calicchio; Gwenaelle S Géléoc; Hart G W Lidov; Sanda Alexandrescu; Maria K Lehtinen
Journal:  Am J Pathol       Date:  2018-03-13       Impact factor: 4.307

9.  Immune response modulation by Galectin-1 in a transgenic model of neuroblastoma.

Authors:  Gabriele Büchel; Johannes H Schulte; Luke Harrison; Katharina Batzke; Ulrich Schüller; Wiebke Hansen; Alexander Schramm
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

Review 10.  Tracing the cellular origin of cancer.

Authors:  Cédric Blanpain
Journal:  Nat Cell Biol       Date:  2013-01-20       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.